/STSS
STSS Stock - Sharps Technology, Inc.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$2.22+10.45%
+$0.21 (+10.45%) • Dec 19
41
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.34
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.44
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for STSS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.20 – $2.24
TARGET (TP)$2.55
STOP LOSS$2.04
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.15
52W High$690.00
52W Low$2.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-773,904 | $-891,248 | $-654,572 | $-28,699 | $-11,038 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-7,856,710 | $-10,126,650 | $-8,738,793 | $-4,497,666 | $-2,333,426 |
| Net Income | $-9,296,202 | $-9,841,638 | $-4,639,662 | $-4,664,412 | $-2,347,162 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-2220.05 | $-251.73 | $28.89 | $-175.57 | $-167.14 |
Company Overview
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
STSSBeat Rate
30%
Last 10 quarters
Avg Surprise
-38.2%
EPS vs Estimate
Beats / Misses
3/7
Last 12 quarters
Latest EPS
$-4.02
Q4 2025
EPS Surprise History
Q1 24
-21.4%
$-0.17vs$-0.14
Q2 24
-25.0%
$-1.10vs$-0.88
Q3 24
-150.0%
$-2.20vs$-0.88
Q4 24
-44.3%
$-1.27vs$-0.88
Q1 25
-339.2%
$-869.70vs$-198.00
Q2 25
No data
Q3 25
+480.9%
$3.58vs$-0.94
Q4 25
-298.0%
$-4.02vs$-1.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | $-1.01 | $-4.02 | -298.0% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-0.94 | $3.58 | +480.9% | ✓ BEAT |
Q2 2025 | May 15, 2025 | — | $38.62 | — | — |
Q1 2025 | Mar 27, 2025 | $-198.00 | $-869.70 | -339.2% | ✗ MISS |
Q4 2024 | Nov 14, 2024 | $-0.88 | $-1.27 | -44.3% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-0.88 | $-2.20 | -150.0% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-0.88 | $-1.10 | -25.0% | ✗ MISS |
Q1 2024 | Mar 29, 2024 | $-0.14 | $-0.17 | -21.4% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-3.74 | $-0.17 | +95.4% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.08 | $-0.22 | -175.0% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-2.86 | $-0.16 | +94.3% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | — | $0.55 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.33 | — | — |
Q3 2022 | Aug 15, 2022 | — | $0.43 | — | — |
Q2 2022 | May 25, 2022 | — | $31485.87 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.20 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.28 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.17 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.19 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.19 | — | — |
Latest News
Sharps Technology shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Dec 15, 2025, 03:32 PM
Sharps Technology Reports $17.7M in Q3 Revenue Gains From Digital Assets and Staking
📈 PositiveBenzinga•Nov 17, 2025, 12:55 PM
Sharps Technology Expands Solana Digital Asset Treasury Strategy Through Strategic Collaboration With Coinbase Global
📈 PositiveBenzinga•Oct 9, 2025, 11:06 AM•Also:
STSS stock has given up its prior gain. Sharps Technology shares were trading higher after the company announced a $100 million stock repurchase program.
📈 PositiveBenzinga•Oct 2, 2025, 02:40 PM
Sharps Technology shares are trading higher after the company announced a $100 million stock repurchase program.
📈 PositiveBenzinga•Oct 2, 2025, 11:02 AM
Sharps Technology Announces Stock Repurchase Program To Acquire Up To $100M Of Outstanding Common Stock
📈 PositiveBenzinga•Oct 2, 2025, 11:01 AM
Sharps Technology Expands Digital Asset Treasury Strategy With Crypto.com Services For Its Holdings
📈 PositiveBenzinga•Sep 29, 2025, 11:12 AM
Sharps Technology Partners With Jupiter Exchange To Stake Over Two Million SOL Strengthening Solana Network Validation And Liquidity
📈 PositiveBenzinga•Sep 23, 2025, 11:04 AM
Sharps Technology Partners With BONK, Stakes Part Of $400M Solana Treasury To Boost Yields
📈 PositiveBenzinga•Sep 16, 2025, 11:01 AM
Sharps Technology Files For Mixed Shelf Offering Of Up To $1B
📉 NegativeBenzinga•Sep 15, 2025, 01:34 PM
STSS stock has given up its prior gain. Sharps Technology shares were trading higher after the company announced a partnership with Pudgy Penguins for exposure and connectivity to the Solana digital asset treasury space.
➖ NeutralBenzinga•Sep 11, 2025, 02:15 PM
Sharps Technology shares are trading higher after the company announced a partnership with Pudgy Penguins for exposure and connectivity to the Solana digital asset treasury space.
📈 PositiveBenzinga•Sep 11, 2025, 01:23 PM
Sharps Technology shares are trading higher after the company announced a partnership with Pudgy Penguins for exposure and connectivity to the Solana digital asset treasury space.
📈 PositiveBenzinga•Sep 10, 2025, 08:21 PM
Sharps Technology Partners With Pudgy Penguins To Expand Solana Digital Asset Treasury Exposure
📈 PositiveBenzinga•Sep 10, 2025, 08:10 PM
Sharps Technology shares are trading lower after the company announced a $236.6 million at-the-market offering agreement.
📉 NegativeBenzinga•Sep 2, 2025, 04:15 PM
Sharps Technology Announces $236.6M At-The-Market Offering Agreement
➖ NeutralBenzinga•Sep 2, 2025, 01:25 PM
Sharps Technology Builds $400M SOL Treasury With Acquisition Of Over 2MSolana Native Tokens
📈 PositiveBenzinga•Sep 2, 2025, 11:03 AM
Sharps Technology Shares Halted On Circuit Breaker To The Upside, Stock Now Down -27.45%
➖ NeutralBenzinga•Aug 29, 2025, 06:44 PM
Sharps Technology Shares Resume Trade
➖ NeutralBenzinga•Aug 29, 2025, 06:43 PM
Sharps Technology Shares Halted On Circuit Breaker To The Downside, Stock Now Down -26.82%
📉 NegativeBenzinga•Aug 29, 2025, 06:33 PM
Frequently Asked Questions about STSS
What is STSS's current stock price?
Sharps Technology, Inc. (STSS) is currently trading at $2.22 per share. The stock has moved +10.45% today.
What is the analyst price target for STSS?
No analyst price targets are currently available for this stock.
What sector is Sharps Technology, Inc. in?
Sharps Technology, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is STSS's market cap?
Sharps Technology, Inc. has a market capitalization of $0.06 billion, making it a small-cap company.
Does STSS pay dividends?
No, Sharps Technology, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCCLD
CareCloud, Inc.
$3.21
Mkt Cap: $0.1B
CGTX
Cognition Therapeutics, Inc.
$1.54
Mkt Cap: $0.1B
GLSI
Greenwich LifeSciences, Inc.
$13.01
Mkt Cap: $0.2B
IXHL
Incannex Healthcare Limited
$0.44
Mkt Cap: $0.0B
JYNT
The Joint Corp.
$9.00
Mkt Cap: $0.1B
LUCD
Lucid Diagnostics Inc.
$1.12
Mkt Cap: $0.1B
MBOT
Microbot Medical Inc.
$2.08
Mkt Cap: $0.1B
PDEX
Pro-Dex, Inc.
$38.68
Mkt Cap: $0.1B
RPID
Rapid Micro Biosystems, Inc.
$3.15
Mkt Cap: $0.1B
SERA
Sera Prognostics, Inc.
$3.55
Mkt Cap: $0.1B
Explore stocks similar to STSS for comparison